Effects of Total Extract of Dracocephalum moldavica on Ischemia/Reperfusion Induced Arrhythmias and Infarct Size in the Isolated Rat Heart

Document Type: Original Article

Authors

1 Department of Pharmacology, School of Pharmacy, Drug Applied Research Center and Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran

2 Department of Pharmacology, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

3 Department of Pharmacognosy, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

4 Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran

Abstract

Objective(s)
Dracocephalum moldavica (D. moldavica) have been traditionally used as a cardiotonic agent in the folk medicine of some regions of Iran. In the present study, effects of total extract of D. moldavica on ischemia/reperfusion induced arrhythmias and infarct size investigated in isolated rat heart.
Materials and Methods
The isolated hearts were mounted on a Langendorff apparatus then perfused during 30 min regional ischemia and 120 min reperfusion, either by a modified Krebs-Henseleit solution as the control group or by enriched Krebs solution with total extract of D. moldavica (25-200 µg/ml) as the treatment groups[A1] . The ECGs recorded and analyzed to determine cardiac arrhythmias. At the end of the reperfusion, the hearts stained by Evans blue solution then incubated by triphenyltetrazolium chloride. The volume of infarcted tissue and percentage of infarct size determined by computerized planimetry.
Results
The results demonstrated that total extract of D. moldavica caused a significant reduction in the number of ventricular tachycardia (VT), total ventricular ectopic beats (VEBs) and VT duration in ischemic and reperfusion periods. The incidence of ischemic VT reduced[DN2]  from 93% in the control group to 0, 50 and 50% in the treatment groups. The infarct size was 37±1% in the control group, however, perfusion of the extract (25, 50, 200 µg/ml) reduced it to 13±2, 8±1 and 18±2%, respectively (P<0.001). In addition, the extract remarkably lowered volume of infarcted tissue compared to the control group (P<0.05).
Conclusion
Our findings showed cardioprotective effects of total extract of D. moldavica against ischemia/reperfusion injuries in the isolated rat heart.



 

Keywords


1. Dastmalchi K. Chemical composition and in vitro antioxidative assessment of Moldavian balm (Dracocephalum moldavica L.) extracts. In: Young scientists symposium: Future Trends in Phytochemistry, June 28-July 1, 2006, Olomouc, Czech Republic. Available from http://rustreg.upol.cz/pse.

2. Anonymus Medicinal plants, Islamic Azad University of Juybar webpage. 2006, Available from http://Juybar.blogfa.com.

3. Ghannadi A, Sajjadi SE, Abedi D, Yousefi J, Daraei-Ardekani R. The in vitro activity of seven Iranian plants of the Lamiaceae family against Helicobacter pylori. Niger J Nat Prod Med  2004; 8:40– 42.

4. Omidbeigi R. Strategies of production and processing of medicinal herbs. Tehran: Tarrahan Nashr Press; 1997.

5. Zargari A. Medicinal plants. Tehran: Tehran University Press; 1990.

6. Leung AY, Foster S. Encyclopedia of common natural ingredients. New York: John Wiley & Sons; 1996.

7. Lee JY, Hwang WI, Lim ST. Antioxidant and anticancer activities of organic extracts from Platycodon grandiflorum De Candolle roots. J Ethnopharmacol 2004; 93:409- 415.

8. Ford  DA. Alterations in myocardial lipid metabolism during myocardial ischemia and reperfusion. Prog Lipid Res  2002; 41: 6-26.

9. Dastmalchi K, Damien Dorman HJ, Kos-ar M, Hiltunen R. Chemical composition and in vitro antioxidant evaluation of a water soluble Moldavian balm (Dracocephalum moldavica L.) extract. LWT-Food Sci Technol 2007; 40:239–248.

10. Gu HF, Chen RY, Sun YH, Xing JG. Studies on chemical constituents in herbs of Dracocephalum moldavica. China J Mater Med 2005; 30:671-679.

11. Scherer R, Teixeira GH. Antioxidant activity index (AAI) by the 2, 2- diphenyl-1-picrylhydrazyl method. Food Chem 2008; 112:654-658.

12. Middleton E, Kamdaswami C, Theoharides TC. Effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and canser.Pharmacol Rev 2000; 52:673-751.

13. Duke J. Handbook of biologically active phytochemicals and their activities. London: CRC Press; 1992. 157.

14. Dastmalchi K. Chemical composition and antioxidative activity of Moldavian balm (Dracocephalum moldavica L.) extracts. PhD thesis. Helsinki, Finland: 2006.

15. Delazar A, Shoeb M, Kumarasamy Y, Byres M, Nahar L, Modarresi M, et al. Two bioactive ferulic acid derivatives from Eremostachys Glabra. Daru 2004; 12:49-53.

16. Najafi M, Garjani A. Study the effect of L-carnitine on infarct size in the ischemic-reperfused isolated rat hearts. Pharm Sci J 2005; 1:47-52.

17. Kristiansen SB, Nielsen–Kudsk JE, Botker HE, Nielsen TT. Effects of KATP channel modulation on myocardial glycogen content, lactate and amino acids in non-ischemic and ischemic rat hearts. J Cardiovasc Pharmacol  2005; 45:456–461.

18. Najafi M, Garjani A. The effect of L-carnitine on arrhythmias in the ischemic rat heart. Iran J Basic Med Sci  2005; 8:38-44.

19. Garjani A, Nazemiyeh H, Maleki N, Valizadeh H. Effects of extracts from flowering tops of Crataegus meyeri A. Pojark. on ischemic arrhythmias in anaesthetized rats. Phytother Res 2000; 14:428-431.

20. Najafi M, Garjani A, Eteraf Oskouei T. Comparison between the effects of ischemic preconditioning and pharmacologic preconditioning by L-carnitine on infarct zone size in the ischemic-reperfused isolated rat heart. Iran J Basic Med Sci 2007; 10: 54-59.

21. Kim GT, Chun YS, Park JW, Kim MS. Role of apoptosis–inducing factor in myocardial cell death by ischemia-reperfusion. Biochem Biophys Res Commun 2003; 309:619- 624.

22. Zacharowski K, Blackburn B, Thiemermann C. Ranolazine, A partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat. Eur J Pharmacol 2001; 418: 105-110.

23. Selwyn AP, Braunwald E. Ischemic heart diseases. In: Kasper LD, Fauci SA, editors. Harrison’s Principles of Internal Medicine. 16th ed. New York:  The Mc Graw- Hill companies; 2004. p. 1435- 1444.

24. Peg rat–Millard MN, Cuvelier ME, Berset C. Antioxidant activity of phenolic compounds in 2, 2-azo bis                (2-amidinopropane) dihydrochloride (AAPH) - induced oxidation: synergistic and antagonistic effects. J Am Oil Chemist Soc 2003; 80:1007-1012.

25. Polilaityee V, Venskutonis PR. Antioxidative activity of purple peril (Perilla frutescens L.), Moldavian dragonhead (Dracocephalum moldavica L.), and Roman chamomile (Anthemis nobilis L.) extracts in grape seed oil. J Am Oil Chemist Soc 2000; 77:951-956.

26. Jenkins DJA, Kendall CWC, D’Costa MA, Jackson CJA, Vidgen E, Singer W, et al. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men. J Urol  2003; 169:507-511.

27. Kim SH, Kang KW, Kim KW, Kim ND. Procyanidins in crataegus extract evoke endothelium-dependent  vasorelaxation in rat aorta. Life Sci 2000; 67:121-131.

28. Davidson J, Connor K. Herbs for the mind. New York: Guilford publication; 1943. 178-182.

29. Baharvand B, Esmaili Dehaj M, Rasoulian B, Namdari M, Shikhani Y, Asghar Kiani A. Delayed anti-arrhythmic effect of nitroglycerin in anesthetized rats: Involvement of CGRP, PKC and mKATP channels. Int J Cardiol 2008; Available online 26 June 2008.

30. Sadraei H, Ghannadi A, Malekshahi K. Relaxant effect of essential oil of Melissa officinalis and citral on rat ileum contractions. Fitoterapia 2003; 74:445-452.

31. Hume RJ, Grant OA. Agents used in cardiac arrhythmias. In: Katzung GB, editor. Basic and clinical pharmacology. 10th ed. New York: The Mc Graw- Hill companies; 2007. p. 211-235.